Publication:

Assessing Ovarian Cancer Risk When Considering Elective Oophorectomy at the Time of Hysterectomy

Loading...
Thumbnail Image

Date

2011

Journal Title

Journal ISSN

Volume Title

Publisher

Ovid Technologies (Wolters Kluwer Health)
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Vitonis, Allison F., Linda Titus-Ernstoff, and Daniel W. Cramer. 2011. “Assessing Ovarian Cancer Risk When Considering Elective Oophorectomy at the Time of Hysterectomy.” Obstetrics & Gynecology 117 (5) (May): 1042–1050. doi:10.1097/aog.0b013e318212fcb7.

Abstract

Objective

To develop a risk-factor score that may provide additional guidance to women and their physicians regarding elective bilateral salpingo-oophorectomy at the time of hysterectomy.

Methods

From a case–control study conducted from 1992 to 2008 in women residing in eastern Massachusetts or New Hampshire, we selected 1,098 women with invasive ovarian cancer (case group) and 1,363 for the control group who were older than 40 years and had neither hysterectomy nor a personal or family history of breast or ovarian cancer. Using logistic regression, we identified key risk factors and built a risk score. The score was separately assessed in 126 women in the case group and 156 in the control group with excluded prior hysterectomy to determine whether women who developed ovarian cancer could have been distinguished.

Results

Summing eight conditions found to be associated with ovarian cancer (Jewish ethnicity, less than 1 year of oral contraceptive use, nulliparity, no breastfeeding, no tubal ligation, painful periods or endometriosis, polycystic ovary syndrome or obesity, talc use), we created a five-level score. Assigning average risk to those with a score of 2, the odds ratios varied from 0.56 (95% confidence interval [CI] 0.42–0.74) for a score of 0–1 to 3.30 (95% CI 2.50–4.35) for a score of 5 or greater (P trend <.001). The risk score was higher for women who developed ovarian cancer after hysterectomy than those who did not (P=.01). Lifetime risks for ovarian cancer for a woman at age 40 years are changed from 1.2% with a 0–1 score to 6.6% with a score of 5 or higher.

Conclusion

We developed a risk-assessment tool that can quantify women's risk for ovarian cancer and should be validated in other data sets.

Description

Research Data

Keywords

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories